Amneal Pharmaceuticals, Inc. AMRX Other Income (Expense)
Other Income (Expense) at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s other income (expense)?
- Amneal Pharmaceuticals, Inc. (AMRX) reported other income (expense) of -$61.6M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s other income (expense) changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s other income (expense) increased by 2.0% year-over-year, from -$62.86M to -$61.6M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s other income (expense)?
- Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s other income (expense) has grown at a 20.4% compound annual growth rate (CAGR), from -$121.35M to -$254.89M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.